Seizure Response to Cannabidiol in a State-Sponsored Open-Label Program

被引：0
|
作者：
Szaflarski, Jerzy [5 ]
Bebing, E. [3 ]
DeWolfe, Jennifer [5 ]
Dure, Leon [5 ]
Gaston, Tyler
Harsanyi, Krisztina [4 ]
Houston, James
McGrath, Tony [2 ]
Perry, Leslie [5 ]
Singh, Rani [1 ]
Thomas, Ashley [5 ]
Hoef, Lawrence Ver
机构：
[1] Childrens Alabama, Dept Neurol, Birmingham, AL USA
[2] UAB Childrens Hosp, Div Ped Neuro, Birmingham, AL USA
[3] UAB Epilepsy Ctr, Huntsville, AL USA
[4] UAB Pediat Neurol, Birmingham, AL USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S14.006
引用
收藏
页数：2
相关论文
共 50 条
  • [1] STATE-SPONSORED INTERNATIONAL TERRORISM - THE PROBLEMS OF RESPONSE
    WILKINSON, P
    [J]. WORLD TODAY, 1984, 40 (07): : 292 - 298
  • [2] THE LIBYAN SANCTIONS - A RATIONAL RESPONSE TO STATE-SPONSORED TERRORISM
    BIALOS, JP
    JUSTER, KI
    [J]. VIRGINIA JOURNAL OF INTERNATIONAL LAW, 1986, 26 (04): : 799 - 855
  • [3] State-sponsored gayness: Ghettoization as a response to HIV/AIDS
    Smith, G
    Bartos, M
    [J]. AIDS: ACTIVISM AND ALLIANCES, 1997, : 213 - 225
  • [4] Consumer Preferences for State-Sponsored Designations: The Case of the Missouri Grown Label
    Grashuis, Jasper
    Su, Ye
    [J]. JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS, 2022, 48 (01) : 103 - 116
  • [5] IMPROVEMENTS IN SEIZURE FREQUENCY PARALLEL IMPROVEMENTS IN SEIZURE SEVERITY IN AN OPEN LABEL STUDY OF CANNABIDIOL
    Szaflarski, J. P.
    Bebin, E. M.
    Gaston, T.
    Grayson, L.
    Liu, Y.
    Cutter, G.
    DeWolfe, J.
    Dure, L.
    Hansen, B.
    Hirsanyi, K.
    Houston, J. T.
    Kankirawatana, P.
    McGrath, T.
    Singh, R.
    Thomas, A.
    Ver Hoef, L.
    [J]. EPILEPSIA, 2017, 58 : S158 - S158
  • [6] Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
    Gaston, Tyler E.
    Bebin, E. Martina
    Cutter, Gary R.
    Ampah, Steve B.
    Liu, Yuliang
    Grayson, Leslie P.
    Szaflarski, Jerzy P.
    [J]. EPILEPSY & BEHAVIOR, 2019, 98 : 201 - 206
  • [7] An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
    Bawa, Zeeta
    Lewis, Daniel
    Gavin, Paul D.
    Libinaki, Roksan
    Joubran, Lida
    El-Tamimy, Mahmoud
    Taylor, Greg
    Meltzer, Ryan
    Bedoya-Perez, Miguel
    Kevin, Richard C.
    Mcgregor, Iain S.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Cannabidiol in treatment of refractory epileptic spasms: An open-label study
    Herlopian, Aline
    Hess, Evan J.
    Barnett, James
    Geffrey, Alexandra L.
    Pollack, Sarah F.
    Skirvin, Lauren
    Bruno, Patricia
    Sourbron, Jo
    Thiele, Elizabeth A.
    [J]. EPILEPSY & BEHAVIOR, 2020, 106
  • [9] EXPERIENCES OF A STATE-SPONSORED NOTIFICATION AND SCREENING-PROGRAM FOR ASBESTOS WORKERS
    BENDER, AP
    WILLIAMS, AN
    PARKER, DL
    [J]. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1993, 23 (01) : 161 - 169
  • [10] Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program
    Gaston, Tyler E.
    Bebin, E. Martina
    Cutter, Gary R.
    Grayson, Leslie
    Szaflarski, Jerzy P.
    [J]. EPILEPSIA OPEN, 2023, 8 (04) : 1405 - 1412
12345